Altogether, our findings highlight that, in addition to its already known role as an oncosuppressor miRNA in NSCLC, miR-34c-3p acts in KRAS-mutated NSCLC as a regulator of the CDK1 gene, which is involved in a synthetic lethality pathway (Fig. 7). The gene discussed is KRAS; the disease is non-small cell lung carcinoma.